
Please try another search
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States and Australia. Its products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also offers disposable, Lumos Leelu, and hand-held readers. The company was incorporated in 2018 and is based in Carlsbad, California.
Name | Age | Since | Title |
---|---|---|---|
Samuel Lanyon | - | 2019 | Non-Executive Chairman |
Douglas Ward | - | 2022 | CEO, MD & Director |
Bronwyn Le Grice | - | 2020 | Independent Director |
Catherine A. Robson | - | 2020 | Independent Director |
Jerome M. Adams | 50 | 2021 | Strategic Healthcare Adviser & Member of Medical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review